At a glance
- Originator Kao Corporation
- Class Anti-ischaemics; Benzofurans; Small molecules; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial ischaemia
Most Recent Events
- 31 May 2001 Discontinued-Preclinical for Myocardial ischaemia in Japan (Unknown route)
- 17 Oct 1994 Preclinical development for Myocardial ischaemia in Japan (Unknown route)